Summit Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Summit Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Summit Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $11M, a 25.8% increase year-over-year.
  • Summit Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $51M, a 261% increase year-over-year.
  • Summit Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2024 was $51M, a 261% increase from 2023.
  • Summit Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14.1M, a 18.1% increase from 2022.
  • Summit Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.9M, a 6.69% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $51M +$36.9M +261% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-24
2023 $14.1M +$2.16M +18.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-24
2022 $11.9M -$856K -6.69% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-24
2021 $12.8M +$11M +625% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $1.77M +$921K +109% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-12-21
2019 $845K -$5.45M -86.6% Feb 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $6.3M +$4.2M +201% Feb 1, 2018 Jan 31, 2019 10-K 2021-03-31
2017 $2.09M Feb 1, 2017 Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.